These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 16682521)
1. Blastic natural killer (NK) cell leukemia (agranular CD4+CD56+ leukemia). Zhang K; Prichard JW; Brown RE Ann Clin Lab Sci; 2006; 36(2):212-5. PubMed ID: 16682521 [TBL] [Abstract][Full Text] [Related]
2. Blastic NK-cell-like lymphoma with T-cell receptor gene rearrangement. Liu XY; Atkins RC; Feusner JH; Rowland JM Am J Hematol; 2004 Apr; 75(4):251-3. PubMed ID: 15054822 [TBL] [Abstract][Full Text] [Related]
3. CD4+/CD56+ hematodermic neoplasm: blastic NK cell lymphoma in a 6-year-old child: report of a case and review of literature. Eguaras AV; Lo RW; Veloso JD; Tan VG; Enriquez ML; Del Rosario ML J Pediatr Hematol Oncol; 2007 Nov; 29(11):766-9. PubMed ID: 17984695 [TBL] [Abstract][Full Text] [Related]
4. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse. Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062 [TBL] [Abstract][Full Text] [Related]
5. Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement. Suzuki R; Nakamura S; Suzumiya J; Ichimura K; Ichikawa M; Ogata K; Kura Y; Aikawa K; Teshima H; Sako M; Kojima H; Nishio M; Yoshino T; Sugimori H; Kawa K; Oshimi K; Cancer; 2005 Sep; 104(5):1022-31. PubMed ID: 15999368 [TBL] [Abstract][Full Text] [Related]
6. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia. Khoury JD; Medeiros LJ; Manning JT; Sulak LE; Bueso-Ramos C; Jones D Cancer; 2002 May; 94(9):2401-8. PubMed ID: 12015765 [TBL] [Abstract][Full Text] [Related]
11. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells. Herling M; Jones D Am J Clin Pathol; 2007 May; 127(5):687-700. PubMed ID: 17439829 [TBL] [Abstract][Full Text] [Related]
12. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. Petrella T; Bagot M; Willemze R; Beylot-Barry M; Vergier B; Delaunay M; Meijer CJ; Courville P; Joly P; Grange F; De Muret A; Machet L; Dompmartin A; Bosq J; Durlach A; Bernard P; Dalac S; Dechelotte P; D'Incan M; Wechsler J; Teitell MA Am J Clin Pathol; 2005 May; 123(5):662-75. PubMed ID: 15981806 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic cues for natural killer cell lymphoma: primary nodal presentation and the role of in situ hybridisation for Epstein-Barr virus encoded early small RNA in detecting occult bone marrow involvement. Chim CS; Ma ES; Loong F; Kwong YL J Clin Pathol; 2005 Apr; 58(4):443-5. PubMed ID: 15790718 [TBL] [Abstract][Full Text] [Related]
18. NK cell lymphoblastic lymphoma in the masticator space: a case of non-Hodgkin lymphoma with challenging maxillofacial manifestation and immunophenotype. Imai T; Michizawa M; Degami H Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Dec; 108(6):897-903. PubMed ID: 19846330 [TBL] [Abstract][Full Text] [Related]
19. Blastic natural killer cell lymphoma/leukemia: a report of seven cases. Bayerl MG; Rakozy CK; Mohamed AN; Vo TD; Long M; Eilender D; Palutke M Am J Clin Pathol; 2002 Jan; 117(1):41-50. PubMed ID: 11789729 [TBL] [Abstract][Full Text] [Related]
20. Progress in understanding and managing natural killer-cell malignancies. Oshimi K Br J Haematol; 2007 Nov; 139(4):532-44. PubMed ID: 17916099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]